Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative to Wegovy and injectable GLP-1s for weight loss.

| MNT RESOURCE |
 |
| What to know about malabsorption |
|
|
 |
| Malabsorption occurs when the body is unable to absorb nutrients from the diet. Learn about symptoms, what can cause malabsorption, and how it is treated. |
| Malabsorption occurs when the body is unable to absorb nutrients from the diet. Learn about symptoms, what can cause malabsorption, and how it is treated. |
|
 |
READ ON  |
|
|
|
| |
|
|
We'd love to hear from you in the meantime, so please send any feedback, comments, suggestions, or questions to the team by email.
Reminder: Add newsletter@medicalnewstoday.com to your contact list so you don’t miss a single update.
Kindly,
The Medical News Today team |
| |
|
|
| |
 |
| |
|
|
| |
| You are receiving this newsletter because you subscribed on our web site, Medical News Today. |
| Did a friend send you this email? Subscribe here. |
| View in Browser | Privacy Policy | Unsubscribe |
Our website services, content, and products are for informational purposes only. Medical News Today does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Medical News Today encourages you to make any treatment decisions with your healthcare professional. Medical News Today is owned by RVO Health.
© 2026 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 |
| |
|
|
|
|
Comments
Post a Comment